BioLife Solutions

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BLFS and other ETFs, options, and stocks.

About BLFS

BioLife Solutions, Inc. engages in the development, manufacture and marketing of bio preservation tools for cells and tissues. Its product offerings include proprietary hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs, generic blood stem cell freezing and cell thawing media products and custom product formulation and custom packaging services.

CEO

Roderick de Greef

CEORoderick de Greef

Employees

155

Employees155

Headquarters

Bothell, Washington

HeadquartersBothell, Washington

Founded

1987

Founded1987

Employees

155

Employees155

BLFS Key Statistics

Market cap

1.17B

Market cap1.17B

Price-Earnings ratio

-85.75

Price-Earnings ratio-85.75

Dividend yield

—

Dividend yield—

Average volume

706.61K

Average volume706.61K

High today

$25.07

High today$25.07

Low today

$23.67

Low today$23.67

Open price

$24.69

Open price$24.69

Volume

995.83K

Volume995.83K

52 Week high

$29.62

52 Week high$29.62

52 Week low

$17.86

52 Week low$17.86

Stock Snapshot

BioLife Solutions(BLFS) stock is priced at $23.95, giving the company a market capitalization of 1.17B. It carries a P/E multiple of -85.75.

As of 2026-05-23, BioLife Solutions(BLFS) stock has fluctuated between $23.67 and $25.07. The current price stands at $23.95, placing the stock +1.2% above today's low and -4.5% off the high.

BioLife Solutions(BLFS) shares are trading with a volume of 995.83K, against a daily average of 706.61K.

During the past year, BioLife Solutions(BLFS) stock moved between $17.86 at its lowest and $29.62 at its peak.

BLFS News

TipRanks 2d

Major Stakeholder Makes Bold Move With BioLife Solutions Stock

New insider activity at BioLife Solutions ( (BLFS) ) has taken place on May 21, 2026. Start a conversation with TipRanks’ trusted, data-backed investment intel...

Simply Wall St 3d

Why BioLife Solutions Is Up 13.4% After Q1 Return To Profitability And Reaffirmed Outlook

In the first quarter of 2026, BioLife Solutions, Inc. reported sales of US$27.5 million, up from US$22.05 million a year earlier, and moved from a net loss of U...

Simply Wall St 4d

A Look At BioLife Solutions Valuation After Strong Q1 Results And Reaffirmed 2026 Growth Outlook

Advertisement Why BioLife Solutions stock is back on investors’ radar BioLife Solutions (BLFS) drew fresh attention after first quarter 2026 results showed sa...

Analyst ratings

100%

of 10 ratings

Buy

100%

Hold

Sell

People also own

Based on the portfolios of people who own BLFS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.